Hawthorne Timothy Zef, Shellien Rachel, Chambers Lucy, Devereux Graham
Respiratory Medicine, Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
Respiratory Medicine, Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
BMJ Case Rep. 2021 Apr 23;14(4):e241256. doi: 10.1136/bcr-2020-241256.
This case report discusses the rare presentation of cytomegalovirus (CMV) pneumonitis in a young patient with moderately severe Crohn's disease managed with low dose azathioprine. CMV pneumonitis was initially suspected on CT chest images and confirmed by PCR for CMV. She was treated with intravenous ganciclovir and later stepped down to oral valganciclovir. Although this patient had a prolonged and complicated hospital admission, a good clinical outcome was achieved. CMV infection was raised as an early differential and antiviral treatment was started without delay. This case study, therefore, makes the case for increased awareness of the possibility of, and recognition of CMV pneumonitis among healthcare professionals as a way of preventing significant morbidity and mortality. It also raises awareness of checking for slow metabolisers of azathioprine before initiation to look for individuals who may be at increased risk of azathioprine's adverse effects.
本病例报告讨论了一名患有中度重度克罗恩病并接受低剂量硫唑嘌呤治疗的年轻患者中罕见的巨细胞病毒(CMV)肺炎表现。最初通过胸部CT图像怀疑为CMV肺炎,并通过CMV的PCR检测得以确诊。她接受了静脉注射更昔洛韦治疗,随后改为口服缬更昔洛韦。尽管该患者住院时间延长且病情复杂,但仍取得了良好的临床结果。早期鉴别出CMV感染并立即开始抗病毒治疗。因此,本病例研究表明,医疗保健专业人员应提高对CMV肺炎可能性的认识并能够识别,以此预防严重的发病率和死亡率。它还提高了在开始治疗前检查硫唑嘌呤慢代谢者的意识,以寻找可能有更高硫唑嘌呤不良反应风险的个体。